Inflammation and Alzheimer's disease

Lancet

Volumn 358, Issue 9280, 2001, Pages 436-437

  Jones, Roy W ^a  

^a St Martin's Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ARTHROTEC; BENZODIAZEPINE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; HYDROXYCHLOROQUINE; INDOMETACIN; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; STEROID;

ALZHEIMER DISEASE; BRAIN REGION; CELL ACTIVATION; CLINICAL TRIAL; COGNITIVE DEFECT; HUMAN; IMMUNE RESPONSE; INFLAMMATION; META ANALYSIS; MICROGLIA; NERVE CELL DEGENERATION; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0035845298     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05667-7     Document Type: Note

References (10)

1. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases
2. b-Amyloid protein-induced microglial cell activation
3. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
4. Risk of Alzheimer's disease and duration of NSAID use
5. Clinical trial of indomethacin in Alzheimer's disease
6. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease
7. A randomized controlled trial of prednisone in Alzheimer's disease
8. Results of a double-blind, randomized, placebo-controlled study of celecoxib in the treatment of progression of Alzheimer's disease
9. Microglia: A sensor for pathological events in the CNS
10. Mild cognitive impairment: Clinical characterisation and outcome